Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-12-014726
Filing Date
2012-04-26
Accepted
2012-04-26 13:49:54
Documents
2
Period of Report
2012-04-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3519
2 POWER OF ATTORNEY 2/17/2009 7:51:03 PM doc1.htm EX-24 4831
  Complete submission text file 0001127602-12-014726.txt   9644
Mailing Address 65 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE LEXINGTON MA 02421 781-860-8660
CUBIST PHARMACEUTICALS INC (Issuer) CIK: 0000912183 (see all company filings)

EIN.: 223192085 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 37 WHITETAIL WAY LITTLETON MA 01460
Business Address
STEA GREGORY (Reporting) CIK: 0001456336 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21379 | Film No.: 12782728